AVITA Medical (RCEL) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

AVITA Medical Revenue Highlights


Latest Revenue (Y)

$50.56M

Latest Revenue (Q)

$21.23M

Main Segment (Y)

Foreign

Main Geography (Y)

UNITED STATES

AVITA Medical Revenue by Period


AVITA Medical Revenue by Year

DateRevenueChange
2022-12-31$50.56M254.49%
2021-06-30$14.26M-30.99%
2020-06-30$20.67M2246.74%
2018-06-30$880.67K-25.41%
2017-06-30$1.18M17.83%
2016-06-30$1.00M1.66%
2015-06-30$985.65K-63.27%
2014-06-30$2.68M-4.68%
2013-06-30$2.81M-16.03%
2012-06-30$3.35M0.50%
2011-06-30$3.34M45.24%
2010-06-30$2.30M-2.97%
2009-06-30$2.37M96.64%
2008-06-30$1.20M52.17%
2007-06-30$790.99K-10.46%
2006-06-30$883.39K127.05%
2004-06-30$389.08K100.23%
2002-12-31$194.32K100.00%
2001-12-31-100.00%
2000-12-31-100.00%
1999-12-31--100.00%
1998-12-31$582.97K100.00%
1997-12-31-100.00%
1996-12-31-100.00%
1995-12-31-100.00%
1994-12-31-100.00%
1993-12-31--

AVITA Medical generated $50.56M in revenue during NA 2022, up 254.49% compared to the previous quarter, and up 5045.97% compared to the same period a year ago.

AVITA Medical Revenue by Quarter

DateRevenueChange
2023-09-30$21.23M20.29%
2023-06-30$17.65M67.26%
2023-03-31$10.55M11.58%
2022-12-31$9.46M-33.49%
2022-09-30$14.22M17.75%
2022-06-30$12.07M19.83%
2022-03-31$10.07M5.53%
2021-12-31$9.55M35.98%
2021-09-30$7.02M-31.87%
2021-06-30$10.30M-10.70%
2021-03-31$11.54M74.34%
2020-12-31$6.62M-6.36%
2020-09-30$7.07M25.81%
2020-06-30$5.62M-10.89%
2020-03-31$6.30M35.73%
2019-12-31$4.64M-3.54%
2019-09-30$4.82M-

AVITA Medical generated $21.23M in revenue during Q3 2023, up 20.29% compared to the previous quarter, and up 175.82% compared to the same period a year ago.

AVITA Medical Revenue Breakdown


AVITA Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 22Jun 21Jun 20
Foreign$160.00K$171.00K-
Recell System-$435.00K-

AVITA Medical's latest annual revenue breakdown by segment (product or service), as of Dec 22: Foreign (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20
Recell System$399.00K$408.00K$416.00K$432.00K$435.00K$435.00K$435.00K$4.10M----
Foreign---$39.00K$15.00K$30.00K$10.00K-----

AVITA Medical's latest quarterly revenue breakdown by segment (product or service), as of Sep 23: Recell System (100.00%).

AVITA Medical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 22Jun 21Jun 20
UNITED STATES$33.26M$28.95M$13.80M

AVITA Medical's latest annual revenue breakdown by geography, as of Dec 22: UNITED STATES (100.00%).

Quarterly Revenue by Country

CountrySep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Sep 21Jun 21Mar 21Dec 20Sep 20
JAPAN$581.00K$708.00K$1.02M---------
AUSTRALIA$61.00K$33.00K$62.00K---------
UNITED STATES$12.96M$10.99M$9.43M$8.59M$9.00M$8.28M$7.40M$10.24M$8.72M$5.02M$4.97M-
U S-------$6.92M----

AVITA Medical's latest quarterly revenue breakdown by geography, as of Sep 23: UNITED STATES (95.28%), JAPAN (4.27%), and AUSTRALIA (0.45%).

AVITA Medical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
VREXVarex Imaging$893.40M$209.10M
TMDXTransMedics Group$241.62M$114.31M
AXGNAxoGen$159.01M$47.91M
SIBNSI-BONE$138.89M$39.97M
RXSTRxSight$89.08M$45.52M
SGHTSight Sciences$81.06M$21.37M
LUNGPulmonx$68.67M$20.78M
IRMDIRadimed$65.56M$17.93M
NPCENeuroPace$65.42M$18.12M
TELATELA Bio$58.45M$16.09M
APYXApyx Medical$52.35M$12.15M
RCELAVITA Medical$50.56M$21.23M
CVRXCVRx$39.30M$11.81M
TBIOTelesis Bio$27.51M$3.44M
CLPTClearPoint Neuro$23.95M$7.86M
DCTHDelcath Systems$2.06M$7.77M
OFIXOrthofix Medical$100.00K$198.62M

RCEL Revenue FAQ


AVITA Medical's yearly revenue for 2022 was $50.56M, representing an increase of 254.49% compared to 2021. The company's yearly revenue for 2020 was $14.26M, representing a decrease of -30.99% compared to 2019. RCEL's yearly revenue for 2019 was $20.67M, representing an increase of 2246.74% compared to 2018.

AVITA Medical's quarterly revenue for Q3 2023 was $21.23M, a 20.29% increase from the previous quarter (Q2 2023), and a 49.32% increase year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $17.65M, a 67.26% increase from the previous quarter (Q1 2023), and a 46.17% increase year-over-year (Q2 2022). RCEL's quarterly revenue for Q1 2023 was $10.55M, a 11.58% increase from the previous quarter (Q4 2022), and a 4.72% increase year-over-year (Q1 2022).

AVITA Medical's revenue growth rate for the last 3 years (2019-2022) was 144.65%, and for the last 5 years (2016-2022) was 4182.54%.

AVITA Medical's revenue streams in c 22 are Foreign

For the fiscal year ending Dec 22, the largest source of revenue of AVITA Medical was Foreign. This segment made a revenue of $160K, representing 100.00% of the company's total revenue.